Recital 17, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 1×

Whereas significant progress in the treatment of diseases has already been made thanks to the existence of medicinal products derived from elements isolated from the human body and/or otherwise produced, such medicinal products resulting from technical processes aimed at obtaining elements similar in structure to those existing naturally in the human body and whereas, consequently, research aimed at obtaining and isolating such elements valuable to medicinal production should be encouraged by means of the patent system;

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    The preamble to the Directive states as follows: ‘… Whereas, in particular in the field of genetic engineering, research and development require a considerable amount of high-risk investment and therefore only adequate legal protection …

    18 Oct 2011 · 62010CJ0034